These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8694618)

  • 1. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass.
    Huyzen RJ; van Oeveren W; Wei F; Stellingwerf P; Boonstra PW; Gu YJ
    Ann Thorac Surg; 1996 Aug; 62(2):533-7. PubMed ID: 8694618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
    Srivastava AR; Banerjee A; Misra BB; Minhas H; Virmani S
    J Card Surg; 2008; 23(3):239-45. PubMed ID: 18435639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE; Shupak RC; Pontius J; Rao AK
    Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
    London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose thrombin time versus the activated clotting time during cardiopulmonary bypass.
    de Jong MA
    J Extra Corpor Technol; 1999 Jun; 31(2):76-9. PubMed ID: 10724646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin management during cardiac surgery with respect to various blood-conservation techniques.
    Boldt J; Zickmann B; Herold C; Scholz S; Dapper F; Hempelmann G
    Surgery; 1992 Mar; 111(3):260-5. PubMed ID: 1542853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated clotting time, anticoagulation, use of heparin, and thrombin activation during extracorporeal circulation: changes under aprotinin therapy.
    Feindt P; Volkmer I; Seyfert U; Huwer H; Kalweit G; Gams E
    Thorac Cardiovasc Surg; 1993 Feb; 41(1):9-15. PubMed ID: 7690165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.
    Wang JS; Lin CY; Karp RB
    Anesth Analg; 1994 Jul; 79(1):9-13. PubMed ID: 8010461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
    Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
    Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
    Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
    Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.